SYNOPSIS Humoral antibodies to skeletal muscle and its components and to thymus have been demonstrated in the sera of patients with myasthenia gravis. A role for cellular hypersensitivity to similar antigens in the pathogenesis of the disease has been suggested by some reports of the presence of cellular immunity. A detailed immunological study using muscle and thymic antigens, including those prepared from the patients' own tissues, failed to confirm these findings. It is suggested that previous reports of cellular hypersensitivity represent the demonstration of an epiphenomenon.
There is good evidence that immunological mechanisms are involved in the pathogenesis of myasthenia gravis (Simpson, 1960 (Simpson, , 1975 . The strongest argument is the fact that the thymus gland is histologically abnormal in more than 80% of cases; in about 7000 medullary germinal centres are found and in about 10% a thymoma is present (Castleman and Norris, 1949) . The proportion of patients in whom myasthenia is associated with a thymoma has been reported as from 10-30% of cases but the incidence increases with age and the overall percentage is therefore approximately 10% (Castleman, 1955; Simpson, 1958) . Medullary germinal centres similar to those found in myasthenia are also seen in other disorders presumed to have an autohypersensitivity basis-for example, thyrotoxicosis and Addison's disease (Sloan, 1943) , thyroiditis (Gunn et al., 1964) , and systemic lupus erythematosus (Goldstein and Mackay, 1967) . The centres have also, however, been seen in young normal subjects dying suddenly (Middleton, 1967) or undergoing cardiac surgery for congenital anomalies (Vetters and Barclay, 1973) and therefore their importance seems debatable (Vetters and Simpson, 1974) .
There is a definite clinical association between myasthenia gravis and other presumed auto- ' This work was supported by the Muscular Dystrophy Group of Great Britain.
2 Reprint requests to: W. M. H. Behan, Department of Pathology, Western Infirmary, Glasgow GI1 6NT. (Accepted 9 May 1975.) immune disorders-for example, rheumatoid arthritis (Simpson, 1960) , systemic lupus erythematosus (Wolf and Barrows, 1966 ), Sjogren's disease (Brown et al., 1968) , pernicious anaemia (Simpson, 1960 (Simpson, , 1964 Bletcher and Williams, 1967) , pemphigus (Beutner et al., 1968; , autoimmune haemolytic anaemia (Cohen and Waxman, 1967; Halperrin et al., 1966 ), Hashimoto's thyroiditis (Simpson, 1964) , and thyrotoxicosis and hypothyroidism (Osserman et al., 1967; Simpson, 1968) . Serological abnormalities including rheumatoid factor, antinuclear antibodies, thyroid and haemolytic autoantibodies have been frequently demonstrated in myasthenia (van der Geld et al., 1963; Adner et al., 1964; Simpson, 1964) . Abnormalities in IgA metabolism have also been found in these patients (Behan et al., in preparation (Strauss et al., 1965; Nastuk et al., 1966; Vetters, 1967) , tanned red cell agglutination (Djanian et al., 1964) , and precipitation in gels (Shulman et al., 1966) . Strauss et al. (1965) originally demonstrated that the serum of 3000 of myasthenics, and of almost all patients with myas-thenia gravis and a thymoma, contained antibody to muscle demonstrable on immunofluorescent staining. They used 900 control cases consisting of normal subjects and patients with a great variety of neurological disorders and showed that all but one were negative. Other workers have reported positive immunofluorescence in normal undiluted serum but Strauss used serum at a dilution of 1 in 60 and considered the reaction that he found was specific and characteristic of the disease.
The role of these antibodies in disease pathogenesis, however, is doubtful since antibodies are not present in the majority of patients with myasthenia and, even when present, there tends to be no correlation between the antibody titre and the course and severity of the disease (Oosterhuis et al., 1967) . Mothers with myasthenia have been found to show high antibody titres with no symptomatology in the neonate and the reverse has been described (Oosterhuis et al., 1966) . Again, patients with a thymoma often have high titres of anti-muscle antibody and yet show no evidence of myasthenia even on detailed electrophysiological testing (McFarlin et al., 1966) . Theoretically, it is also difficult to account for a transmission defect produced by anti-muscle antibodies involving myofibrils rather than by a process which affects the motor end-plates.
The original suggestion of Simpson (1960) (Soborg and Bendixen, 1967; Rosenberg and David, 1970) . These antigens were prepared similarly (1) to those used in other reports which had claimed positive cell mediated immune responses (Alpert et al., 1972; Armstrong et al., 1973; Kott et al., 1973; Goust et al., 1974) , or those which had been claimed to induce an experimental thymitis and a partial neuromuscular block in guinea-pigs (Kalden et al., 1973) , and (2) to those antigens which react specifically with the sera of patients with myasthenia (Aarli, 1972 Absence of cellular hypersensitivity to muscle and thynmic antigens in myasthenia gravis pH 7.2. The homogenate was centrifuged for 10 minutes at 2 500 g and the supernatant then used to prepare the fractions needed. First the supernatant was centrifuged for 30 minutes at 10 000 g at 4°C. The sediment was discarded and the supernatant further centrifuged in a Beckman vacuum ultracentrifuge at 105 000 g for one hour. The final sediment obtained (so-called microsomal fraction) and the supernatant (so-called soluble fraction) were lyophilized. The lyophilized fractions were prepared for use by dissolving in RPMI 1640 tissue culture fluid and making up to concentrations of 500 ,ug/ml (microsomal fraction) and 500 ,ug/ml and 250 ,ug/ml (soluble fraction). These concentrations were determined to be non-cytotoxic by previous dose-response measurements.
c. Preparation ofcitric acid extract ofmuscle Skeletal muscle was thawed, minced, and washed in cold phosphate buffered saline repeatedly until the supernatant was free of all discoloration. A citric acid extract was then prepared as described by Espinosa and Kaplan (1968) and used by Aarli (1972 Soborg and Bendixen (1967) with modifications as indicated. Essentially 50 ml venous blood was taken under sterile conditions into a syringe containing 1 000 units of preservative-free heparin and 10 ml dextran. The blood was then allowed to sediment at 37°C for 20 minutes. All but the bottom 0.5 cm of leucocyte-rich plasma was removed and the suspension then centrifuged at 250 g for 10 minutes. Nine volumes of 0.83% ammonium chloride were added and the cells resuspended and left in this solution for four minutes exactly. (The ammonium chloride lysed the red cells present.) The cells were then centrifuged at 200 g and washed twice in RPMI 1640 tissue culture fluid and then once in RPMI 1640 to which 10% fetal calf serum had been added and 1.0% penicillin and streptomycin. After the final wash the cell pellet was suspended in the residual fluid and a trial capillary filled and sealed with Critoseal. This capillary was centrifuged at 200 g for four minutes and the concentration of the cell suspension remaining was adjusted so that after dilution with antigen (1/5 dilution) a length of 2-3 mm of the capillary would be filled with packed cells. Usually between 2.2 and 2.8 ml of cell suspension of the required concentration was obtained, meaning that a total of between 22 and 28 chambers (each containing two capillaries) could be set up. The cell suspension was then divided into at least nine aliquots of 0.2 ml. Each aliquot was incubated with 0.05 ml of one of the various antigens (and one aliquot had 0.05 ml of RPMI 1640 alone added) for two hours at 37°C. Thus a minimum of two chambers was set up for each antigen and the controls. If the number of cells permitted, the aliquots of each cell suspension and the antigen were increased accordingly. At the end of the two hour incubation period haematocrit tubes were filled with the cell suspensions sealed at one end with Critoseal and centrifuged at 200 g for four minutes. The tubes were cut at the cell-fluid interphase and the cell bearing ends of two capillaries placed in each small culture chamber group.bmj.com on May 29, 2017 -Published by http://jnnp.bmj.com/ Downloaded from detected cell-mediated immunityto streptokinase/ streptodornase (SKSD) but we were unable to show similar sensitivity to any of the skeletal muscle or thymic antigens employed in our experimental subjects. These results, therefore, conflict with those of other workers who, using the same technique, claim to have found hypersensitivity to muscle and thymic antigens in patients with myasthenia. Alpert et al. (1972) obtained positive inhibitory responses to crude skeletal muscle and myosincontaining fractions in 14 of 21 myasthenics. They considered inhibition of migration of more than 3000 to be significant: 12 of their patients showed this degree of inhibition but inhibition to the same antigens of up to 10% was also present in their control subjects. No positive control antigens were used in the system-for example, PPD, candida, or SKSD but with nonspecific proteins, such as meconium extract, they obtained greater than 20% migration inhibition in some patients. A strong positive correlation was noted between the degree of cell-mediated immunity and the titre of humoral muscle antibodies. Armstrong et al. (1973) , using thymic lymphocytes, found cellular hypersensitivity to crude muscle and crude thymus antigens in myasthenic patients but also reported similar sensitivity to muscle in nearly 5000 of their control subjects. In addition, they obtained a positive response in a patient with a thymoma who did not have myasthenia gravis. Kott et al. (1973) showed positive in vitro responses to crude muscle and myosin-containing fractions as antigen in 63% of their patients with myasthenia gravis. They noted, however, poor correlation between cellmediated immunity and the presence of humoral antibodies but they were able to demonstrate a correlation between the stage of the disease and cell-mediated or humoral immunity. The authors stated that tuberculin was used as a positive control antigen but these particular results were not presented. Goust et al. (1974) found cell-mediated immunity to muscle and thymic antigens in 45 of their 46 patients. They used monkey muscle and thymus and human muscle as antigens. They demonstrated that some of their patients responded only to human muscle and others only to monkey muscle and one to monkey thymus only. They noted that 'no correlation appears to exist between the clinical and pathological data' and presence of a thymoma, thymectomy, or a changing clinical state did not influence the results of their test. No control antigens of any sort were used and some of their control subjects had inhibition of 20-35% to the muscle and thymus used as antigen. Positive responses to the muscle extracts were also found in 12 of 14 patients with polymyositis but without myasthenia gravis.
A criticism that can be made of all these reports is that positive control antigens were not used. In addition, dose response curves were not employed to measure cellular hypersensitivity when present. In our experiments, increasing the dose of antigen had no effect, whereas if sensitivity were present one would expect some increase of inhibition with an increase in antigen concentration. Furthermore, Goust et al. (1974) noted that enhancement of macrophage migration was present in 10 cases at one or both of the antigen concentrations used and they stated that 'in myasthenia gravis, with this technique, an augmentation of the migration index seems as significant as a depression'. Augmentation is found in the macrophage migration inhibition test when no sensitivity exists, so that this statement is open to criticism.
A non-specific inhibition ofmacrophage migration may occur due to differing histocompatibility antigens. Falk et al. (1970) showed that non-sensitized lymphocytes were stimulated to produce macrophage inhibiting factor on contact with different histocompatibility antigens. We used autologous antigens in some of our experiments in order to eliminate this effect but the phenomenon may help to explain, in part, the inhibition noted by other workers.
Our findings do agree with those of experimenters who used different in vitro methods to try to detect cell-mediated immunity to muscle and thymic antigens in patients with myasthenia gravis. Houseleyand Oppenheim(1967) and Lisak and Zweiman (1975) , employing the technique of measuring lymphocyte proliferative responses, were unable to showanysensitivityin patients with myasthenia. Similarly, Abramsky et al. (1975) , using a lymphocyte transformation method, found no response to crude muscle antigen in the myasthenic patients they investigated.
The inhibition which has been observed is most likely an epiphenomenon. Indeed, Alpert et al. (1972) point out in the interpretation of their results that the findings need not reflect a primary immunological effect but rather 'may simply reflect a cellular response to tissue alteration resulting from another cause'. This was also the opinion of Lisak and Zweiman (1975) who stated 'it would be somewhat surprising if such reactivity (cell-mediated immunity) was pathogenic in the face of the disparate clinical features of the two disorders' (the other condition they referred to was polymyositis in which cellmediated immunity has been shown by Currie et al. 1971) .
The specificity and significance of cell-mediated immune responses to muscle in myasthenia gravis is questioned because of the demonstration of similar sensitivity in patients with muscular dystrophy , polymyalgia rheumatica (Esiri et al., 1973) , and Guillain-Barre syndrome . Furthermore, Kott et al. (1971) have reported sensitivity to central nervous system antigens in patients with myasthenia gravis have found similar reactivity to these same antigens in patients with muscular dystrophy.
The possibility that muscle and thymic antigens might be involved in the pathogenesis of myasthenia gravis, however, is also suggested by the work of Goldstein and Whittingham (1966) and Kalden and Irvine (1969) who claim that myasthenia gravis can be produced in guineapigs by immunizing them with these antigens. Several other investigators, however, have been unable to confirm their findings (Kaufmann et al., 1969; Namba and Grob, 1969; Vetters et al., 1969; Behan, 1974) . None of the animals immunized by the former workers developed clinical disease and subtle electrophysiological changes were used as the criteria for diagnosis of myasthenia. These changes are non-specific and open to differing interpretations (Vetters et al., 1969; Brooks, 1971) . The antigens used by Kalden et al. (1973) failed to elicit any positive responses in our system.
The occurrence of myasthenia gravis in association with diseases in which there is anergyfor example, chronic lymphatic leukaemia (Cohen and Waxman, 1967) , lymphosarcoma (Simpson, 1960 ), Hodgkin's disease, systemic lupus erythematosus (Wolf and Barrows, 1966) , and sarcoidosis (Simpson, 1960; 1964 )-militates against cell-mediated hypersensitivity being involved in the pathogenesis of the disease. Fudenberg (1971) has postulated that there is a depression of T-cell function rather than a hyperallergic state in the autoimmune disorders. In fact, myasthenic patients show impaired immune responses to dinitrochlorobenzene (DNCB) sensitization (Adner et al., 1964 ).
An association between certain histocompatibility antigens and myasthenia has also been demonstrated recently (Pirskanen et al., 1972; Behan et al., 1973) . HLA-8 has been found to occur with a very high frequency in myasthenia gravis, gluten enteropathy, dermatitis herpetiformis, and autoimmune thyroiditis (Dausset et al., 1974) . It is claimed that HLA-8 is associated with disorders of impaired immunity (Da Costa et al., 1974) .
Our work, therefore, provides no evidence to support the theory that cell-mediated immunity to muscle or thymic antigens is involved in the pathogenesis of myasthenia gravis. The most likely explanation for the previous reports of such cellular hypersensitivity is that these findings represent an epiphenomenon and not true cellmediated immunity. 
